Vimarsana
Biggest News Aggregation in the World

Vifor Pharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vifor Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vifor Pharma Today - Breaking & Trending Today

Formycon invites to the Annual General Meeting on June 12, 2024 in Munich - Vimarsana News

Formycon invites to the Annual General Meeting on June 12, 2024 in Munich

EQS-News: Formycon AG / Key word: AGM/EGM/Personnel Formycon invites to the Annual General Meeting on June 12, 2024 in Munich 07.05.2024 / 11:00 CET/CEST The issuer...

European Competition Law Newsletter – May 2024 | McGuireWoods LLP - Vimarsana News

European Competition Law Newsletter – May 2024 | McGuireWoods LLP

Not A Good Idea: UK CMA Investigates National Nail Tech Price Increase Day - In an effort to “help nail pros grow and scale,” The Nail Tech Org (TNTO), a UK-based online...

EU and UK Consider First Stand-Alone Disparagement Cases | Skadden, Arps, Slate, Meagher & Flom LLP - Vimarsana News

EU and UK Consider First Stand-Alone Disparagement Cases | Skadden, Arps, Slate, Meagher & Flom LLP

The development of case law on disparagement has, to date, been driven mainly by the French competition authority, or has been addressed under consumer protection or other national...

European Commission's First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy | Goodwin - Vimarsana News

European Commission's First-Ever Abuse of Dominance Probe for Shelving of a Novel Pipeline Therapy | Goodwin

The European Commission (EC) has launched a formal investigation under its abuse of dominance rules into US life sciences company Zoetis in the area of novel veterinary medicines. The...

Vifor Pharma offers to rectify anti-competitive behaviour against rival - Vimarsana News

Vifor Pharma offers to rectify anti-competitive behaviour against rival

Drug maker Vifor Pharma has offered to rectify its disparaging campaign against the closest rival to its blockbuster iron deficiency medicine Ferinject, EU antitrust regulators said on Friday, a move...